Cusick M, Libbey J, Fujinami R
Future Virol. 2014; 9(5):475-482.
PMID: 25214881
PMC: 4157677.
DOI: 10.2217/fvl.14.26.
Olson G, DENT P, Rawls W, South M, Montgomery J, Melnick J
J Exp Med. 1968; 128(1):47-68.
PMID: 5662017
PMC: 2138505.
DOI: 10.1084/jem.128.1.47.
Naccarato R, Fagliolo U, Farini R
Postgrad Med J. 1971; 47(546):244.
PMID: 5576494
PMC: 2467084.
DOI: 10.1136/pgmj.47.546.244.
Jurgensen J, Abraham J, HARDY W
Am J Dig Dis. 1970; 15(6):577-81.
PMID: 5445639
DOI: 10.1007/BF02238120.
Simpson B, Walton B, Strunin L
Br Med J. 1972; 4(5835):296-7.
PMID: 5083900
PMC: 1788810.
DOI: 10.1136/bmj.4.5835.296-b.
Chromosome abnormalities in chronic active hepatitis.
Stefanescu D, Moanga M, Teodorescu M, Brucher J
J Clin Pathol. 1972; 25(8):705-7.
PMID: 5076805
PMC: 477482.
DOI: 10.1136/jcp.25.8.705.
Australia (hepatitis-associated) antigen: physicochemical and immunological characteristics.
LE BOUVIER G, McCOLLUM R
Adv Virus Res. 1970; 16:357-96.
PMID: 4993220
PMC: 7131679.
DOI: 10.1016/s0065-3527(08)60027-5.
Viral hepatitis and agranulocytosis.
Nagaraju M, Weitzman S, Baumann G
Am J Dig Dis. 1973; 18(3):247-52.
PMID: 4688574
DOI: 10.1007/BF01071979.
Australia antigen and cell-mediated immunity.
Reisenbuk V, Ioks S
Arch Gesamte Virusforsch. 1974; 45(1-2):141-3.
PMID: 4547148
DOI: 10.1007/BF01240552.
Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.
MacSween R, Thomas M
Clin Exp Immunol. 1973; 15(4):523-33.
PMID: 4544318
PMC: 1553970.
Fulminant hepatitis associated with acquired defect in humoral immunity.
Greally J, Dillon J, Mayne B
Ir J Med Sci. 1974; 143(6):350-5.
PMID: 4436022
DOI: 10.1007/BF03004789.
[Disturbance of the cellular immunoreaction at the initial stage of acute infectious hepatitis].
Pappas A, PHLIPPEN R, Putz T, SCHEURLEN P
Klin Wochenschr. 1970; 48(22):1362-5.
PMID: 4320174
DOI: 10.1007/BF01485464.
[Differential reaction of lymphocytes to phytohemagglutinin (PHA) in liver diseases].
Rossler R, Havemann K, Dolle W
Klin Wochenschr. 1969; 47(15):803-6.
PMID: 4316538
DOI: 10.1007/BF01882306.
Chromosomal aberrations in infective hepatitis.
MATSANIOTIS N, KIOSSOGLOU K, MAOUNIS F, Anagnostakis D
J Clin Pathol. 1970; 23(7):553-7.
PMID: 4249440
PMC: 476834.
DOI: 10.1136/jcp.23.7.553.
[Lymphocyte culture and its relation to clinical problems].
AMBS E
Klin Wochenschr. 1969; 47(15):789-99.
PMID: 4194171
DOI: 10.1007/BF01882304.
Drug use patterns: implications for the acquired immunodeficiency syndrome.
Brown Jr L, Evans R, Murphy D, Primm B
J Natl Med Assoc. 1986; 78(12):1145-51.
PMID: 3806689
PMC: 2571406.
Hepatitis B viral markers in pregnant women and newborn infants in Korea.
Ryoo Y, Chang Y, Choi G, Jeong W, Kim J, Joung N
Korean J Intern Med. 1987; 2(2):258-68.
PMID: 3154838
PMC: 4534940.
DOI: 10.3904/kjim.1987.2.2.258.
Lymphocyte populations in acute viral gastroenteritis.
Dolin R, Reichman R, Fauci A
Infect Immun. 1976; 14(2):422-8.
PMID: 1085751
PMC: 420901.
DOI: 10.1128/iai.14.2.422-428.1976.
Cell-mediated immunity in acute and chronic hepatitis.
Wands J, Perrotto J, Alpert E, Isselbacher K
J Clin Invest. 1975; 55(5):921-9.
PMID: 1079030
PMC: 301836.
DOI: 10.1172/JCI108021.
Chronic active hepatitis in patients with and without hepatitis B surface antigenemia.
Par A, BARNA K, BAJTAI G, Balazs M, PATAKFALVI A, Gogl A
Infection. 1977; 5(3):152-8.
PMID: 914364
DOI: 10.1007/BF01639751.